|
|
| Model Number |
PCO1510OSX |
| Medical Device Problem Codes |
Migration or Expulsion of Device (1395); Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Abdominal Pain (1685); Abscess (1690); Purulent Discharge (1812); Erythema (1840); Fever (1858); Hemorrhage/Blood Loss/Bleeding (1888); Unspecified Infection (1930); Inflammation (1932); Nausea (1970); Pain (1994); Scar Tissue (2060); Vomiting (2144); Hernia (2240); Discomfort (2330); Ascites (2596); Constipation (3274); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after the implant, the patient experienced recurrence, infection, abscess, pain and mesh was bunched up in several places.Post-operative patient treatment included revision surgery.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after the implant, the patient experienced mesh migration, inflammation, abdominal pain, recurrence, infection, abscess, pain and mesh was bunched up in several places.Post-operative patient treatment included medication, revision surgery, exploratory laparotomy, mesh removal, and primary closure of abdominal wall.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional info: a2 (date of birth), a3a, a4, b5, b7, h6 (patient codes, imf codes).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional info: a1, a4, b2, b5, b6, b7, d4 (unique identifier (udi) #), d6b, g1, h6 (patient codes, ime e2402: labs abnormal for wbc, sinus, thickened tissue), <(>&<)> additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after the implant, the patient experienced mesh migration, inflammation, abdominal pain, recurrence, infection, abscess, pain, mesh was bunched up in several places, fluid collection, labs abnormal for wbc, hemorrhage, granulation tissue, tenderness, erythema, constipation, nausea, vomiting, fever, scarring, sinus, thickened inflamed tissue, <(>&<)> purulent material.Post-operative patient treatment included medication, revision surgery, exploratory laparotomy, mesh removal, primary closure of abdominal wall, ct scan, jp drains indwelling, hospitalization, iv fluids, antiemetics, pain management, removal of jp drains, iv antibiotics, wound care, wound vac, <(>&<)> physical therapy.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|